O
Oxford Nanopore Technologies
Developing a new generation of nanopore-based electronic systems for analysis of single molecules
At a glance
- Founded
- 2005
- Headquarters
- Oxford, United Kingdom
- Listing
- IPO 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- IGIP Group
Series A1 investor entered at this stage
- WMWoodford Investment Management
Series B and later18 investors entered at this stage
GIC- M&M&G
- IPInvesco Perpetual
- OIOxford University Innovation
- OROracle
- UOUniversity of Oxford
- GHGT Healthcare
- NINikon
- CBChina Construction Bank
Wellington Management- LPLansdowne Partners
- TVTop Technology Ventures
- ICInternational Holding Company
- AMAmgen
- RRRPMI Railpen
Temasek- HOHostplus
Illumina
Source: Dealroom Talent Intelligence.
Alumni founders
Former Oxford Nanopore Technologies employees who went on to found companies, sorted by Dealroom signal score.
PBPortal BiotechEst. 2021
Andrew HeronUnited Kingdom
Danny GrannickUnited States
HOHoneycombEst. 2014
KNKnomeEst. 2007
George ChurchUnited StatesGlobal footprint
team presence
across markets
Patents
174 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Oxford Nanopore Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oxford Nanopore Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
